Navigation Links
Leading IVF Practice to Open 11th New England Location
Date:1/24/2008

Reproductive Science Center to Open Melrose, Massachusetts Location in

February

LEXINGTON, Mass., Jan. 24 /PRNewswire/ -- Reproductive Science Center of New England announces the opening of a new office in Melrose, Mass. to serve the needs of patients who live in Melrose, Wakefield and Malden. The Melrose office, located at 830 Main Street, Suite 207, will begin scheduling patients for February.

The new location will offer diagnostic as well as other fertility consultations for patients in the area. In vitro fertilization (IVF) procedures -- which include egg retrievals, embryo transfers and embryo cryopreservation -- will continue to be performed at RSC's centrally located Lexington, Mass. office.

"This is an opportunity for Melrose and Wakefield area patients to gain access to RSC's diagnostic and monitoring services in a more convenient location," said Dr. Isaac Z. Glatstein, associate medical director at RSC. "We understand our patients have busy schedules and want to make their infertility treatment as comfortable and convenient as possible."

The Melrose, Mass. office is RSC's 11th New England-area location. In addition to Melrose, RSC has locations in Lexington, Braintree, Cambridge, Gardner, Milford, Peabody, and Westborough, Mass.; Bedford, N.H.; and Providence, R.I.

The office will be open February 14. Appointments can be scheduled by calling 1.800.858.4832. Additional information about RSC can be found on their Web site: http://www.RSCNewEngland.com.

About Reproductive Science Center (RSC)

With 11 locations throughout New England, Reproductive Science Center is the seventh largest medical practice of its kind nationwide, known coast to coast for its innovative patient care, advanced laboratory capabilities and for success rates that are among the highest in the United States. Founded in 1988, RSC is led today by a team of six physicians -- four of whom are women, making it one of the largest groups of female reproductive endocrinologists in the Northeast. RSC is a member of IntegraMed America, an exclusive network limited to the highest performing infertility practices in larger metro areas around the United States. Nearly one out of every four IVF procedures in the United States is performed in an IntegraMed practice. For more information, visit http://www.RSCNewEngland.com.


'/>"/>
SOURCE Reproductive Science Center of New England
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Long Term Care Insurance Leader Offers Advice on Preventing Dementia, the Leading Cause of Care Claims
2. Snap Fitness Launches Partnerships with Leading Online Health & Fitness Companies
3. Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise
4. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
5. Pennsylvanias Leading RN Association Joins CNA/NNOC, Nations Largest Nurses Union
6. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
7. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
8. Leading National Patient Advocacy Group Commends Insurance Industrys Recognition, Focus on Growing National Problem of Uninsured and Underinsured Americans
9. Full-Service Community Hospitals Blast Misleading Letter to Candidates From Limited-Service Hospitals
10. 16-Year-Old Ecuadorian Boy in Dire Need of Dialysis Treatments Thanks One of Nations Leading Providers for Saving His Life
11. CVS/pharmacy Announces Advisory Panel of Leading Women As Part of For All the Ways You Care Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... Levels of a protein in the blood associated with ... online in the journal Radiology. , Heart disease and brain disease exact a major ... rapidly aging population. Damage to both organs often occurs at a subclinical stage, or ...
(Date:12/7/2016)... ... December 07, 2016 , ... Baciocco Brothers Insurance Agency, a ... the Sacramento/Folsom region, is initiating a charity event to raise support and awareness ... Chance treatment center in Sacramento works to provide area teens and families with ...
(Date:12/7/2016)... ... XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s ... Filamentous Dermatitis Associated with Borrelia Infection” reveals that a condition similar ... the prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is ...
(Date:12/7/2016)... ... December 07, 2016 , ... Texas Premier ... operations" carried out by unethical locksmith companies and is urging Search Engines to ... According to Texas Premier Locksmith, these fraudulent locksmith services take advantage of consumers ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... WellnessPro Plus for consumers and healthcare professionals to manage chronic and acute ... the treatment modalities available in a single device. The announcement is part ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 6, 2016 The pen needles market is ... USD 1.65 billion in 2016, growing at a CAGR ... 2021. Over the years, the pen needles market ... to the growing demand for safety injections in the ... of safety pen needles with an aim to reduce ...
(Date:12/6/2016)... 6, 2016  BTL Aesthetics today announced the ... BTL Vanquish ME device was effectively redesigned for ... the targeted tissue. The result: Significantly better outcomes ... BTL Vanquish ME versus BTL Vanquish. ... and their patients with the most highly-advanced devices ...
(Date:12/6/2016)... , Dec. 6, 2016  Viking Therapeutics, Inc. ... biopharmaceutical company focused on the development of novel ... that the U.S. Food and Drug Administration (FDA) ... the treatment of X-linked adrenoleukodystrophy (X-ALD).  VK0214 is ... agonist that selectively regulates the expression of genes ...
Breaking Medicine Technology: